By Hanna Vioque ( October 21, 2025, 7:58 PM BST) -- Incyte has fought back against the Indian pharmaceutical company Sun Pharma's bid to nix three patents protecting a blockbuster drug treating autoimmune conditions, arguing that once it launches in 2026, Sun Pharma's treatment for hair loss will infringe Incyte's intellectual property. ...

See Full Page